HOME >> BIOLOGY >> NEWS
Silence the gene, save the cell: RNA interference as promising therapy for ALS

Scientists at the Ecole Polytechnique Fdrale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease. Their results will be published in the April issue of Nature Medicine, and in the journal's advanced online publication March 13.

In addition to silencing the mutated gene that causes ALS, the EPFL researchers were able to simultaneously deliver a normal version of the gene to motor neuron cells using a single delivery mechanism. "This is the first proof of principle in the human form of a disease of the nervous system in which you can silence the gene and at the same time produce another normal form of the protein," notes Patrick Aebischer, EPFL President and a co-author of the study.

ALS is a progressive neurological disease that attacks the motor neurons controlling muscles. Although its victims retain all their mental faculties, they experience gradual paralysis and eventually lose all motor function, becoming unable to speak, swallow or breathe. Known also as Lou Gehrig's disease, from the baseball player who succumbed to it, this harrowing disease has no cure and its pathogenesis is not very well understood.

An estimated 5,000 Americans are diagnosed with ALS every year, and most of these cases are "sporadic", with no identifiable cause. About 5-10% of ALS cases are inherited. Of these, 20% have been linked to any of more than 100 mutations in the gene that expresses the superoxide dismutase enzyme (SOD1).

These SOD1 mutations are "toxic gain-of-function mutations," meaning that the protein expressed by the mutated gene has, in addition to all its normal cellular functions, some additional function that makes it toxic to the cell. "Any mutation to the SOD1 gene is fatal to motor neuron cells," Aebischer notes. Recen
'"/>

Contact: Mary Parlange
mary.parlange@epfl.ch
41-21-693-7022
Ecole Polytechnique Fdrale de Lausanne
13-Mar-2005


Page: 1 2 3

Related biology news :

1. Silence of the amoebae
2. Silenced gene in worm shows role in regeneration
3. Silenced gene suggests greater risk, possible marker for African-Americans with prostate cancer
4. Molecule blocks gene, sheds light on liver cancer
5. Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers
6. Biologist to receive $500,000 MacArthur grant for genius in innovative gene, molecule studies
7. Cocaine high caused by interference in neuronal receiving stations
8. 454 Sequencing reveals new pathway in RNA interference
9. RNA interference methods highlighted in Cold Spring Harbor Protocols
10. Scientists identify genetic pathways essential to RNA interference
11. S1P1 essential for tumor growth and is blocked by RNA interference

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2018)... ... December 18, 2018 , ... ... cancers and other serious diseases, today announced the publication of an early feasibility ... treatment of rGBM. , The publication of the study, An Early Feasibility ...
(Date:12/14/2018)... ... 2018 , ... uBiome, the leader in microbial genomics, announced ... and Therapeutics” by the US Patent and Trademark Office on July 11, 2017 ... by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, and ...
(Date:12/13/2018)... ... December 12, 2018 , ... NDA Partners Chief Executive ... prominent Expert Consultants, was recently honored by the American Association of Pharmaceutical Scientists ... in pharmaceutical science, technology, engineering, or education and whose contributions to the pharmaceutical ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first class ... of industry leaders identified by the ASGCT board of directors. In total, the Society ... ASGCT members designing transformative pilot studies in gene and cell therapy as they prepare ...
(Date:1/4/2019)... ... January 03, 2019 , ... ... oncolytic virus-based immunotherapies for cancer, today announced the founding of a scientific and ... input and guidance from key leaders in the Immuno-Oncology field. The founding members ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, ... life sciences industry, unveiled a completely redesigned website at http://www.usdm.com . The ... experience for their valued clients and business partners. , The website has ...
(Date:12/13/2018)... YORK (PRWEB) , ... December 12, 2018 , ... Helping ... Styletto- their new sleek and slim hearing aid within its Vision and Hearing campaign ... hearing loss. , Studies show that despite continued efforts to destigmatize hearing aids ...
Breaking Biology Technology:
Cached News: